Atlas Trials

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Clinical trial NCT03523585 · COMPLETED

Trial details

NCT number
NCT03523585
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-08-01
Primary completion
2022-06-30
Enrollment
608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.